Today: 15 May 2026
Ashtead share price slides as FTSE Russell sets March FTSE 100 exit ahead of NYSE move
31 January 2026
1 min read

Ashtead share price slides as FTSE Russell sets March FTSE 100 exit ahead of NYSE move

London, Jan 31, 2026, 08:57 GMT — Market closed

  • Ashtead will exit the FTSE UK Index Series in early March after moving its primary listing to New York
  • Shares ended Friday at 4,687 pence, slipping 0.8% following a sharper 7.6% fall the previous day
  • The group revealed new share repurchases as part of its ongoing buyback

Ashtead Group plc shares closed the week down following a FTSE Russell announcement that the equipment rental company will exit the FTSE UK Index Series in early March, ahead of its planned move to a primary listing in New York.

This is important since index-tracking funds typically mirror the benchmarks they follow. When a stock gets dropped, these funds often sell off their shares, sparking sharp price swings and heavy trading, even without any fresh earnings updates.

FTSE Russell announced on Jan. 28 that Ashtead shares will convert one-for-one into shares of Sunbelt Rental Holdings, a newly formed U.S. parent company. The last day to trade Ashtead shares is expected to be Feb. 27. Pending court approval, Ashtead will be removed from the FTSE UK Index Series when markets open on March 2.

Ashtead ended Friday at 4,687 pence, slipping 0.8% following a 7.6% drop on Thursday, per Investing.com data. Trading volumes ran above average over both days.

The company added to its buyback activity, purchasing 73,921 shares for treasury on Jan. 28 at an average price of 5,087.635 pence each. This move is part of its share repurchase program capped at $1.5 billion.

In its half-year statement last December, CEO Brendan Horgan revealed a new $1.5bn share buyback program set to start on 2 March 2026, aligning with the planned NYSE re-listing, which remains on schedule. The company also highlighted an investor day scheduled for March in New York City.

Ashtead, known in North America as Sunbelt Rentals, has framed its U.S. listing as a move aligning more closely with the bulk of its operations. Reuters has identified the company as the second-largest equipment rental firm in the U.S.

Traders will keep an eye on index-related positioning heading into the end of February and early March. They’ll also look for updates on the court-led process timeline. The “scheme of arrangement” refers to a court-supervised restructuring method used in the UK to alter a company’s holding structure.

The calendar isn’t set in stone. FTSE Russell noted that its planned index changes hinge on court approval; any hold-up could push back the deletion schedule and affect related trading. Meanwhile, Ashtead’s core rental demand still depends on U.S. construction and project activity.

The next key dates are Feb. 27, marking Ashtead’s final trading day under the current schedule, and March 2, when FTSE Russell plans to drop the stock from the FTSE UK Index Series. On that same day, the new holding company’s shares are set to return to London trading alongside their New York listing.

Stock Market Today

  • Schneider National Inc (SNDR) Surpasses Average Analyst Target Price
    May 15, 2026, 7:03 AM EDT. Shares of Schneider National Inc (SNDR) recently climbed above the average 12-month analyst target price of $28.36, trading at $28.45. This milestone prompts analysts to either downgrade the stock or revise targets higher, depending on business fundamentals. Fourteen analysts tracked by Zacks Investment Research set a range of targets from $23.00 to $35.00, averaging $28.36 with a $3.13 standard deviation. Current ratings include 4 strong buys, 1 buy, 10 holds, and 1 sell, reflecting moderate consensus. The average rating is 2.47, where 1 represents strong buy and 5 strong sell. Investors may consider reassessing SNDR's valuation as it crosses this key analyst benchmark, weighing potential further gains against valuation risks.

Latest articles

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

15 May 2026
U.S. stock futures dropped early Friday, with Nasdaq 100 E-minis down 1.56% and S&P 500 E-minis off 1.07%, as Treasury yields and oil prices surged. Brent crude climbed to $109.19 after Donald Trump warned Iran, while the 10-year Treasury yield hit 4.54%. April retail sales rose 0.5%, dampening hopes for a Fed rate cut. Beijing summit produced no clear breakthrough on Iran.
MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

MRNO Stock Just Jumped Before the Bell. The Bigger Murano Global Test Is Still Ahead

15 May 2026
Murano Global Investments shares surged 67% to $0.49 in U.S. premarket trading Friday on heavy volume, after weeks under pressure from debt issues and a Nasdaq listing warning. The stock closed at $0.29 Thursday and faces an Oct. 5 deadline to regain compliance with Nasdaq’s $1 minimum bid rule. Murano is late filing its annual report and has warned of “substantial doubt” about its ability to continue as a going concern.
Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

15 May 2026
Mobix Labs shares jumped 78.74% to $3.11 Thursday after it signed a non-binding letter of intent to acquire Special Project Delivery, a U.S. critical-minerals and energy-storage platform. The company also amended a convertible note with Leviston Resources, raising principal to $4 million for $833,000 in new cash. SPD was formed in 2019 and is based in Newport Beach, California.
HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

15 May 2026
HCW Biologics posted first-quarter net income of $3.47 million on $6.54 million in revenue, reversing a year-earlier loss, after a licensing deal with Beijing-based Trimmune Biotech. The company remains below Nasdaq’s $1 minimum bid and awaits early human data from its lead autoimmune drug, HCW9302, in alopecia areata. HCW also reported positive animal study results for a lung drug targeting premature infants.
Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results
Previous Story

Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results

Shopify stock slides nearly 9% as Fed-chair jitters build ahead of Feb. 11 earnings
Next Story

Shopify stock slides nearly 9% as Fed-chair jitters build ahead of Feb. 11 earnings

Go toTop